CARDIFF ONCOLOGY INC. - COMMON STOCK

Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update

08 8 2024 15:05:01 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Report Second Quarter 2024 Results and Provide Business Update

01 8 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Present at the Jefferies Healthcare Conference

29 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Present at Upcoming Investor Conferences in May

13 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update

02 5 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update

25 4 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study

08 4 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024

06 3 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

29 2 2024 15:07:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC

29 2 2024 15:06:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Colorectal Cancer Trial (CRDF-004)

29 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference

26 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update

22 2 2024 07:00:00 提供 Nasdaq GlobeNewswire